• Offering fertility patients hope.
  • Patients struggling with fertility issues require an understanding and coordinated care team. Prescribers to care and diagnose, payors to provide adequate coverage and pharmaceutical companies to continue researching. And at Community Care Specialty, we’re here to lead and offer patients the support they deserve.

We are here for our fertility patients. To hear their concerns, celebrate their triumphs and support them during hardships. We are committed to high-touch service and regular communication with patients. Because we are a specialty pharmacy, we are able to act as a one-stop-shop for all needed medications and supplies. We find third-party financial assistance for those who need more help and make sure nothing gets in the way of treatment. We’re here for the patients, their advocates, supporters and health care professionals. And we are here to serve.

  • Alpha-1 Antitrypsin Deficiency Symptoms
  • The first symptoms of AATD usually occur between ages 20 and 40. Symptoms can include shortness of breath, wheezing, and reduced physical endurance, as well as lung infections, vision problems, tiredness, weight loss, and a rapid heartbeat upon standing.

People with severe AATD can develop emphysema early in life (between ages 40 and 50). Emphysema causes a chronic cough, trouble breathing, and wheezing, which is why AATD is often misdiagnosed as asthma.

Other potential complications of AATD include cirrhosis and other liver diseases, often diagnosed in infancy and early childhood. Rarely, people with AATD can develop a painful skin disease called necrotizing panniculitis.

People with AATD are more susceptible to life-threatening lung diseases. Smoking and exposure to tobacco smoke are the most significant risk factors. Exposure to toxic substances, dust, and fumes are also risk factors.

  • Alpha-1 Antitrypsin Deficiency Causes
  • People with AATD inherit the condition from their parents. The most common defective genes tied to AATD are known as S and Z, while M is considered normal. So, a person without AATD will have two M genes (MM). Generally, people with one faulty AAT gene are carriers of the disorder, while people with two faulty AAT genes have the disorder. However, even people with two faulty genes might never have complications or even know they have AATD.

Alpha-1 Antitrypsin Deficiency Treatment

There is no cure for AATD, but the related lung diseases can be treated. Importantly, not smoking (or quitting smoking) will help delay or prevent lung diseases. A healthy diet and a suitable level of regular physical activity will help maintain lung function.

Alpha-1 augmentation therapy might be prescribed in severe cases to help slow a decline in lung function. Augmentation therapy is the infusion of an alpha-1 proteinase inhibitor (A1Pi) into the bloodstream. This can be administered safely at home with the help of a nurse. Community Care Specialty Infusion Group offers multiple brands of A1Pi treatments—including Aralast®, Glassia®, and Zemaira®—and can provide qualified in-home nursing service.

Contact Us

Sending a prescription?

If you are a licensed prescriber, send your completed enrollment form directly to us via fax or mail.

  • Fax toll-free: 973-837-6878
  • Community Care Specialty
  • 225 Route 46 West Suite 3
  • Totowa, NJ, 07512